BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Natural cytotoxicity triggering receptor 1 (NCR1; NKP46; CD335)

April 9, 2015 7:00 AM UTC

Mouse studies suggest inhibiting NKP46 could help treat Type I diabetes. In mice, an antibody against mouse NKP46 decreased expression of the protein on NK cells - which are involved in β cell destruc...